William Chen Email

Chief Technology Officer | Co-Founder . Passkey Therapeutics

Current Roles

Employees:
22
Revenue:
$3.4M
About
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.
Passkey Therapeutics Address

Cambridge, MA
United States
Passkey Therapeutics Email

Past Companies

Stealth Biotech VC NewCoCo-Founder, SVP
Cyrus BiotechnologyScientific Advisory Board Member
Dewpoint TherapeuticsVP, Research and Development